Latest news
Psychedelic Drug Development Takes Center Stage – Do You Have What it Takes to Bring a Psychedelic Drug to Market? - Spencer FaneSpencer Fane · Wed, 05 Aug 2026 17:07:01 GMTFDA Guidance, Clinical Pipelines, and the Emerging Deal Landscape of Psychedelic Therapeutics - JD SupraJD Supra · Wed, 05 Aug 2026 16:55:08 GMTThree potential takeover targets in psychedelics - Pharma VoicePharma Voice · Tue, 04 Aug 2026 13:20:18 GMTPsilocybin Has Crossed the Evidence Threshold. Clinical Guidelines Have Not. - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 12:08:27 GMTAltered States, Standard Rules: FDA Finalizes Guidance on Psychedelic Drug Clinical Trials - ArentFox SchiffArentFox Schiff · Mon, 03 Aug 2026 05:00:00 GMTSafety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial | Communications Medicine - nature.comnature.com · Thu, 30 Jul 2026 07:00:00 GMTTrip Advisor: FDA Publishes Guidance on Psychedelic Drug Trials - The National Law ReviewThe National Law Review · Wed, 29 Jul 2026 22:01:35 GMTEnveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Business WireBusiness Wire · Tue, 28 Jul 2026 07:00:00 GMT